{"transactions":[{"id":1324135,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":84866,"kind":"person","name":"Charlton Ralph William III","position":1,"cik":"0001919397","reported_name":"Charlton Ralph William III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2024-12-21T01:30:02.000Z","date":"2024-12-16","kind":"exercise","planned":false,"acquired":false,"shares":31750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of SPRB common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On December 5, 2022, the Reporting Person was granted 127,000 time-based restricted stock units (\"RSUs\"), subject to a 4-year vesting schedule, with 25% of the total number of RSUs vested on December 15, 2023 (the \"Annual Vesting Date\") and 25% of the total number of RSUs to vest in annual installments on each anniversary of the Annual Vesting Date thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). On December 15, 2024, 31,750 RSUs vested, with 11,329 shares being withheld for taxes, resulting in a net issuance of 20,421 shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On December 5, 2022, the Reporting Person was granted 127,000 time-based restricted stock units (\"RSUs\"), subject to a 4-year vesting schedule, with 25% of the total number of RSUs vested on December 15, 2023 (the \"Annual Vesting Date\") and 25% of the total number of RSUs to vest in annual installments on each anniversary of the Annual Vesting Date thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). On December 15, 2024, 31,750 RSUs vested, with 11,329 shares being withheld for taxes, resulting in a net issuance of 20,421 shares."}],"balance_after":63500,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":31750},"source":{"system":"sec-edgar","filing":"0001415889-24-030001","document":"form4-12212024_011259.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1683553/000141588924030001/form4-12212024_011259.xml","form_type":"4"}},{"id":1324134,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":84866,"kind":"person","name":"Charlton Ralph William III","position":1,"cik":"0001919397","reported_name":"Charlton Ralph William III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2024-12-21T01:30:02.000Z","date":"2024-12-16","kind":"exercise","planned":false,"acquired":false,"shares":26600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of SPRB common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On December 14, 2023, the Reporting Person was granted a total of 212,800 RSUs. 50% or 106,400 of the total RSUs are performance-based and since certain specified performance goals were met, they all vested on December 10, 2024. An additional 106,400 of the total RSUs are time-based. 25% of which vested on December 15, 2024, and in equal annual installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). On December 15, 2024, 26,600 shares vested and 9,491 shares were withheld for taxes, resulting in a net issuance of 17,109 shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On December 14, 2023, the Reporting Person was granted a total of 212,800 RSUs. 50% or 106,400 of the total RSUs are performance-based and since certain specified performance goals were met, they all vested on December 10, 2024. An additional 106,400 of the total RSUs are time-based. 25% of which vested on December 15, 2024, and in equal annual installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). On December 15, 2024, 26,600 shares vested and 9,491 shares were withheld for taxes, resulting in a net issuance of 17,109 shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Represents the aggregate balance of time-based RSUs."}],"balance_after":79800,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":26600},"source":{"system":"sec-edgar","filing":"0001415889-24-030001","document":"form4-12212024_011259.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1683553/000141588924030001/form4-12212024_011259.xml","form_type":"4"}},{"id":1324133,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":84866,"kind":"person","name":"Charlton Ralph William III","position":1,"cik":"0001919397","reported_name":"Charlton Ralph William III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2024-12-21T01:30:02.000Z","date":"2024-12-10","kind":"exercise","planned":false,"acquired":false,"shares":106400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of SPRB common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On December 14, 2023, the Reporting Person was granted a total of 212,800 RSUs. 50% or 106,400 of the total RSUs are performance-based and since certain specified performance goals were met, they all vested on December 10, 2024. An additional 106,400 of the total RSUs are time-based. 25% of which vested on December 15, 2024, and in equal annual installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). On December 15, 2024, 26,600 shares vested and 9,491 shares were withheld for taxes, resulting in a net issuance of 17,109 shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On December 14, 2023, the Reporting Person was granted a total of 212,800 RSUs. 50% or 106,400 of the total RSUs are performance-based and since certain specified performance goals were met, they all vested on December 10, 2024. An additional 106,400 of the total RSUs are time-based. 25% of which vested on December 15, 2024, and in equal annual installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). On December 15, 2024, 26,600 shares vested and 9,491 shares were withheld for taxes, resulting in a net issuance of 17,109 shares."}],"balance_after":106400,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":106400},"source":{"system":"sec-edgar","filing":"0001415889-24-030001","document":"form4-12212024_011259.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1683553/000141588924030001/form4-12212024_011259.xml","form_type":"4"}},{"id":1324132,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":84866,"kind":"person","name":"Charlton Ralph William III","position":1,"cik":"0001919397","reported_name":"Charlton Ralph William III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-12-21T01:30:02.000Z","date":"2024-12-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":11329,"price":0.3887,"value":4403.5823,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On December 5, 2022, the Reporting Person was granted 127,000 time-based restricted stock units (\"RSUs\"), subject to a 4-year vesting schedule, with 25% of the total number of RSUs vested on December 15, 2023 (the \"Annual Vesting Date\") and 25% of the total number of RSUs to vest in annual installments on each anniversary of the Annual Vesting Date thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). On December 15, 2024, 31,750 RSUs vested, with 11,329 shares being withheld for taxes, resulting in a net issuance of 20,421 shares."}],"balance_after":161339,"source":{"system":"sec-edgar","filing":"0001415889-24-030001","document":"form4-12212024_011259.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1683553/000141588924030001/form4-12212024_011259.xml","form_type":"4"}},{"id":1324131,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":84866,"kind":"person","name":"Charlton Ralph William III","position":1,"cik":"0001919397","reported_name":"Charlton Ralph William III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-12-21T01:30:02.000Z","date":"2024-12-16","kind":"exercise","planned":false,"acquired":true,"shares":31750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On December 5, 2022, the Reporting Person was granted 127,000 time-based restricted stock units (\"RSUs\"), subject to a 4-year vesting schedule, with 25% of the total number of RSUs vested on December 15, 2023 (the \"Annual Vesting Date\") and 25% of the total number of RSUs to vest in annual installments on each anniversary of the Annual Vesting Date thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). On December 15, 2024, 31,750 RSUs vested, with 11,329 shares being withheld for taxes, resulting in a net issuance of 20,421 shares."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of SPRB common stock."}],"balance_after":172668,"source":{"system":"sec-edgar","filing":"0001415889-24-030001","document":"form4-12212024_011259.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1683553/000141588924030001/form4-12212024_011259.xml","form_type":"4"}},{"id":1324130,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":84866,"kind":"person","name":"Charlton Ralph William III","position":1,"cik":"0001919397","reported_name":"Charlton Ralph William III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-12-21T01:30:02.000Z","date":"2024-12-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":9491,"price":0.3887,"value":3689.1517,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 14, 2023, the Reporting Person was granted a total of 212,800 RSUs. 50% or 106,400 of the total RSUs are performance-based and since certain specified performance goals were met, they all vested on December 10, 2024. An additional 106,400 of the total RSUs are time-based. 25% of which vested on December 15, 2024, and in equal annual installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). On December 15, 2024, 26,600 shares vested and 9,491 shares were withheld for taxes, resulting in a net issuance of 17,109 shares."}],"balance_after":140918,"source":{"system":"sec-edgar","filing":"0001415889-24-030001","document":"form4-12212024_011259.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1683553/000141588924030001/form4-12212024_011259.xml","form_type":"4"}},{"id":1324129,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":84866,"kind":"person","name":"Charlton Ralph William III","position":1,"cik":"0001919397","reported_name":"Charlton Ralph William III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-12-21T01:30:02.000Z","date":"2024-12-16","kind":"exercise","planned":false,"acquired":true,"shares":26600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 14, 2023, the Reporting Person was granted a total of 212,800 RSUs. 50% or 106,400 of the total RSUs are performance-based and since certain specified performance goals were met, they all vested on December 10, 2024. An additional 106,400 of the total RSUs are time-based. 25% of which vested on December 15, 2024, and in equal annual installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). On December 15, 2024, 26,600 shares vested and 9,491 shares were withheld for taxes, resulting in a net issuance of 17,109 shares."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of SPRB common stock."}],"balance_after":150409,"source":{"system":"sec-edgar","filing":"0001415889-24-030001","document":"form4-12212024_011259.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1683553/000141588924030001/form4-12212024_011259.xml","form_type":"4"}},{"id":1324128,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":84866,"kind":"person","name":"Charlton Ralph William III","position":1,"cik":"0001919397","reported_name":"Charlton Ralph William III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-12-21T01:30:02.000Z","date":"2024-12-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":37964,"price":0.537,"value":20386.668,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 14, 2023, the Reporting Person was granted a total of 212,800 RSUs. 50% or 106,400 of the total RSUs are performance-based and since certain specified performance goals were met, they all vested on December 10, 2024. An additional 106,400 of the total RSUs are time-based. 25% of which vested on December 15, 2024, and in equal annual installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). On December 15, 2024, 26,600 shares vested and 9,491 shares were withheld for taxes, resulting in a net issuance of 17,109 shares."}],"balance_after":123809,"source":{"system":"sec-edgar","filing":"0001415889-24-030001","document":"form4-12212024_011259.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1683553/000141588924030001/form4-12212024_011259.xml","form_type":"4"}},{"id":1324127,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":84866,"kind":"person","name":"Charlton Ralph William III","position":1,"cik":"0001919397","reported_name":"Charlton Ralph William III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-12-21T01:30:02.000Z","date":"2024-12-10","kind":"exercise","planned":false,"acquired":true,"shares":106400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 14, 2023, the Reporting Person was granted a total of 212,800 RSUs. 50% or 106,400 of the total RSUs are performance-based and since certain specified performance goals were met, they all vested on December 10, 2024. An additional 106,400 of the total RSUs are time-based. 25% of which vested on December 15, 2024, and in equal annual installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). On December 15, 2024, 26,600 shares vested and 9,491 shares were withheld for taxes, resulting in a net issuance of 17,109 shares."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of SPRB common stock."}],"balance_after":161773,"source":{"system":"sec-edgar","filing":"0001415889-24-030001","document":"form4-12212024_011259.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683553/000141588924030001/form4-12212024_011259.xml","form_type":"4"}},{"id":1572398,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":84866,"kind":"person","name":"Charlton Ralph William III","position":1,"cik":"0001919397","reported_name":"Charlton Ralph William III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2024-03-18T20:31:58.000Z","date":"2024-03-14","kind":"grant","planned":false,"acquired":true,"shares":106400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of SPRB common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the Reporting Person's Continuous Service as of each such vesting date, 25% of the total number of RSUs vests upon each of the first, second, third and fourth anniversaries of the achievement of a specified clinical development objective."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to the Reporting Person's Continuous Service as of each such vesting date, 25% of the total number of RSUs vests upon each of the first, second, third and fourth anniversaries of the achievement of a specified clinical development objective."}],"balance_after":106400,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":106400},"source":{"system":"sec-edgar","filing":"0001415889-24-008279","document":"form4-03182024_080353.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683553/000141588924008279/form4-03182024_080353.xml","form_type":"4"}},{"id":1692577,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":84866,"kind":"person","name":"Charlton Ralph William III","position":1,"cik":"0001919397","reported_name":"Charlton Ralph William III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-01-03T21:10:08.000Z","date":"2023-12-29","kind":"grant","planned":false,"acquired":true,"shares":9361,"price":0.9775,"value":9150.3775,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired by the Reporting Person pursuant to the Issuer's 2020 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). The Reporting Person acquired the maximum shares allowable pursuant to Section 423 of the Internal Revenue Code."}],"balance_after":55373,"source":{"system":"sec-edgar","filing":"0001209191-24-000339","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683553/000120919124000339/doc4.xml","form_type":"4"}},{"id":1707257,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":84866,"kind":"person","name":"Charlton Ralph William III","position":1,"cik":"0001919397","reported_name":"Charlton Ralph William III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2023-12-19T01:17:05.000Z","date":"2023-12-15","kind":"exercise","planned":false,"acquired":false,"shares":31750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of SPRB common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On December 5, 2022, the Reporting Person was granted 127,000 time-based restricted stock units (\"RSUs\"), subject to a 4-year vesting schedule, with 25% of the total number of RSUs to vest on December 15, 2023 (the \"Annual Vesting Date\") and 25% of the total number of RSUs to vest in annual installments on each anniversary of the Annual Vesting Date thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). On December 15, 2023, 31,750 RSUs vested, with 10,980 shares being withheld for taxes, resulting in a net issuance of 20,770 shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On December 5, 2022, the Reporting Person was granted 127,000 time-based restricted stock units (\"RSUs\"), subject to a 4-year vesting schedule, with 25% of the total number of RSUs to vest on December 15, 2023 (the \"Annual Vesting Date\") and 25% of the total number of RSUs to vest in annual installments on each anniversary of the Annual Vesting Date thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). On December 15, 2023, 31,750 RSUs vested, with 10,980 shares being withheld for taxes, resulting in a net issuance of 20,770 shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Represents the aggregate balance of 95,250 time-based RSUs."}],"balance_after":95250,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":31750},"source":{"system":"sec-edgar","filing":"0001209191-23-059055","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1683553/000120919123059055/doc4.xml","form_type":"4"}},{"id":1707256,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":84866,"kind":"person","name":"Charlton Ralph William III","position":1,"cik":"0001919397","reported_name":"Charlton Ralph William III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2023-12-19T01:17:05.000Z","date":"2023-12-14","kind":"grant","planned":false,"acquired":true,"shares":212800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of SPRB common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"106,400 of the RSUs shall vest as to 25% on December 15, 2024, and in equal annual installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"106,400 of the RSUs shall vest upon the achievement of specified performance goals, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"106,400 of the RSUs shall vest as to 25% on December 15, 2024, and in equal annual installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"106,400 of the RSUs shall vest upon the achievement of specified performance goals, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan)."}],"balance_after":212800,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":212800},"source":{"system":"sec-edgar","filing":"0001209191-23-059055","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1683553/000120919123059055/doc4.xml","form_type":"4"}},{"id":1707255,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":84866,"kind":"person","name":"Charlton Ralph William III","position":1,"cik":"0001919397","reported_name":"Charlton Ralph William III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-12-19T01:17:05.000Z","date":"2023-12-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":10980,"price":1.66,"value":18226.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 5, 2022, the Reporting Person was granted 127,000 time-based restricted stock units (\"RSUs\"), subject to a 4-year vesting schedule, with 25% of the total number of RSUs to vest on December 15, 2023 (the \"Annual Vesting Date\") and 25% of the total number of RSUs to vest in annual installments on each anniversary of the Annual Vesting Date thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). On December 15, 2023, 31,750 RSUs vested, with 10,980 shares being withheld for taxes, resulting in a net issuance of 20,770 shares."}],"balance_after":46012,"source":{"system":"sec-edgar","filing":"0001209191-23-059055","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1683553/000120919123059055/doc4.xml","form_type":"4"}},{"id":1707254,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":84866,"kind":"person","name":"Charlton Ralph William III","position":1,"cik":"0001919397","reported_name":"Charlton Ralph William III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-12-19T01:17:05.000Z","date":"2023-12-15","kind":"exercise","planned":false,"acquired":true,"shares":31750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 5, 2022, the Reporting Person was granted 127,000 time-based restricted stock units (\"RSUs\"), subject to a 4-year vesting schedule, with 25% of the total number of RSUs to vest on December 15, 2023 (the \"Annual Vesting Date\") and 25% of the total number of RSUs to vest in annual installments on each anniversary of the Annual Vesting Date thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). On December 15, 2023, 31,750 RSUs vested, with 10,980 shares being withheld for taxes, resulting in a net issuance of 20,770 shares."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of SPRB common stock."}],"balance_after":56992,"source":{"system":"sec-edgar","filing":"0001209191-23-059055","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683553/000120919123059055/doc4.xml","form_type":"4"}},{"id":1836251,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":84866,"kind":"person","name":"Charlton Ralph William III","position":1,"cik":"0001919397","reported_name":"Charlton Ralph William III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-07-05T22:03:29.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":12378,"price":0.9775,"value":12099.495,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired by the Reporting Person pursuant to the Issuer's 2020 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":25242,"source":{"system":"sec-edgar","filing":"0001209191-23-041267","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683553/000120919123041267/doc4.xml","form_type":"4"}},{"id":2062741,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":84866,"kind":"person","name":"Charlton Ralph William III","position":1,"cik":"0001919397","reported_name":"Charlton Ralph William III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-01-06T01:13:40.000Z","date":"2022-12-30","kind":"grant","acquired":true,"shares":12864,"price":0.9328,"value":11999.5392,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired by the Reporting Person pursuant to the Issuer's 2020 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":12864,"source":{"system":"sec-edgar","filing":"0001209191-23-002153","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683553/000120919123002153/doc4.xml","form_type":"4"}},{"id":2093294,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":84866,"kind":"person","name":"Charlton Ralph William III","position":1,"cik":"0001919397","reported_name":"Charlton Ralph William III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2022-12-08T01:06:02.000Z","date":"2022-12-05","kind":"grant","acquired":true,"shares":127000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest over four years. 25% of the RSUs will vest on December 15, 2023 (the \"Annual Vesting Date\"), and 25% of the total number of RSUs will vest in annual installments on each anniversary of the Annual Vesting Date thereafter, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest over four years. 25% of the RSUs will vest on December 15, 2023 (the \"Annual Vesting Date\"), and 25% of the total number of RSUs will vest in annual installments on each anniversary of the Annual Vesting Date thereafter, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan)."}],"balance_after":127000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":127000},"source":{"system":"sec-edgar","filing":"0001209191-22-060278","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683553/000120919122060278/doc4.xml","form_type":"4"}},{"id":2311258,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":84866,"kind":"person","name":"Charlton Ralph William III","position":1,"cik":"0001919397","reported_name":"Charlton Ralph William III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-04-02T00:04:05.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the stock option vest over a four-year period commencing on the vesting commencement date of March 28, 2022 (\"Vesting Commencement Date\").  1/4th of the total number of shares will vest and become exercisable on the first anniversary of the Vesting Commencement Date, and 1/36th of the remaining shares will vest and become exercisable on a monthly basis thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan)."}],"balance_after":250000,"derivative":{"exercise_price":2.13,"expiration_date":"2032-03-31","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001209191-22-022108","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683553/000120919122022108/doc4.xml","form_type":"4"}}]}